|
0
|
|
Canonical and isomiR products of miR-142 enhance dendritic cell reprogramming.
(linkinghub.elsevier.com)
|
Arh N
…
Pereira CF
Cell Reports
2026-08-12
|
#microrna
#reprogramming
#dendritic cell
#immunotherapy
#immunity
|
|
0
|
|
Biomarkers of nivolumab benefit in resectable non-small cell lung cancer.
(nature.com)
|
Cascone T
…
Provencio M
Nature
2026-08-12
|
#immunotherapy
#biomarker
#lung cancer
#ctdna
#mrd
|
|
0
|
|
TIM3-targeted delivery of venetoclax overcomes drug resistance and reinvigorates NK cell activity in acute myeloid leukemia.
(nature.com)
|
Wang Q
…
Qian P
Nature Cancer
2026-08-12
|
#immunotherapy
#leukemia
#amr
#nanoparticles
#transcriptomics
|
|
0
|
|
Mutant p53 reactivation and DNA demethylation in the treatment of AML/MDS.
(science.org)
|
Song H
…
Lu M
Science Translational Medicine
2026-08-12
|
#p53
#leukemia
#methylation
#immunotherapy
#mutagenesis
|
|
0
|
|
Preclinical evaluation of nitrated alpha-synuclein-specific CAR-Treg therapy in Parkinson's disease.
(linkinghub.elsevier.com)
|
Ugalde V
…
Pacheco R
Cell Reports Medicine
2026-08-12
|
#immunotherapy
#neurodegeneration
#neuroinflammation
#car-t
|
|
0
|
|
Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.
(linkinghub.elsevier.com)
|
Motzer RJ
…
Schmidinger M
The Lancet
2026-08-12
|
#renal cell carcinoma
#clinical trial
#immunotherapy
#oncology
#tyrosine-kinase-inhibitors
|
|
0
|
|
Cofilin1-driven cytoskeletal remodeling modulates pan-cancer CD8(+) T cell immunotherapy responses.
(linkinghub.elsevier.com)
|
Li L
…
Wang Z
Cell Reports Medicine
2026-08-12
|
#immunotherapy
#t-cells
#cancer
#cytoskeleton
#immunosuppression
|
|
0
|
|
Zinc displacement and metabolic interference: cobalt ion-mediated therapy for broad-spectrum CRKP-resistant pneumonia via inhalable microspheres.
(nature.com)
|
Chu Z
…
Qian H
Nature Communications
2026-08-12
|
#amr
#pneumonia
#drug delivery
#biofilm
#immunotherapy
|
|
0
|
|
IL-2 mutein-engrafted antibody MHS552 selectively expands functional regulatory T cells in nonclinical models and healthy participants.
(nature.com)
|
Radanovic I
…
Gabrysova L
Nature Communications
2026-08-12
|
#immunotherapy
#regulatory t cells
#autoimmune
#clinical trial
#interleukin-2
|
|
0
|
|
CD5(+) dendritic cell robots mediated in situ immunocyte activation.
(science.org)
|
Li C
…
Li T
Science Advances
2026-08-12
|
#immunotherapy
#dendritic cell
#tumor microenvironment
#microrobots
#immunoengineering
|
|
0
|
|
Proteogenomic characterization of pulmonary large-cell neuroendocrine carcinoma identifies molecular features and therapeutic strategy.
(science.org)
|
Zhang L
…
Zhang P
Science Advances
2026-08-12
|
#neuroendocrine
#lung cancer
#proteogenomics
#immunotherapy
#biomarker
|
|
0
|
|
Discovery and design of potent cell surface display elements.
(nature.com)
|
Fang Z
…
Chen S
Nature Biotechnology
2026-08-12
|
#cell-surface-display
#immunotherapy
#deep learning
#protein design
#car-t
|
|
0
|
|
BCG vaccination with adjunctive APRIL immunotherapy reduces tuberculosis relapse in mice.
(academic.oup.com)
|
Tsai CY
…
Gengenbacher M
Journal of Infectious Diseases
2026-08-12
|
#tb
#vaccination
#immunotherapy
#immunity
|
|
0
|
|
Spi-B and IRF1 activate tumor immunogenicity downstream of the Epstein-Barr virus protein LMP1.
(linkinghub.elsevier.com)
|
Yamane K
…
Yasuda T
Cell Reports
2026-08-12
|
#immunotherapy
#immunogenicity
#antigen-presentation
#tumor-immunology
#transcription-factors
|
|
0
|
|
First-line PD-1/VEGF bispecific antibody plus chemotherapy in triple-negative breast cancer: a phase 2 trial.
(nature.com)
|
Shao X
…
Ouyang Q
Nature Medicine
2026-08-12
|
#clinical trial
#immunotherapy
#breast cancer
#chemotherapy
|
|
0
|
|
In vivo genome-wide CRISPR screens of human T cells in solid tumours.
(nature.com)
|
Liu Q
…
Carnevale J
Nature
2026-08-12
|
#immunotherapy
#crispr
#t-cells
#cancer
#screening
|
|
0
|
|
Consensus on standardized later-line systemic therapy for hepatocellular carcinoma.
(linkinghub.elsevier.com)
|
Yu H
…
Lu Y
Drug Resistance Updates
2026-08-12
|
#hepatocellular carcinoma
#immunotherapy
#targeted therapy
#oncology
#treatment-resistance
|